Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital
- PMID: 33123776
- PMCID: PMC7595566
- DOI: 10.1007/s00066-020-01698-6
Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital
Erratum in
-
Correction to: Managing patient flows in radiation oncology during the COVID-19 pandemic : Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital.Strahlenther Onkol. 2021 Feb;197(2):158. doi: 10.1007/s00066-020-01724-7. Strahlenther Onkol. 2021. PMID: 33324998 Free PMC article. No abstract available.
Abstract
Purpose: The described work aimed to avoid cancellations of indispensable treatments by implementing active patient flow management practices and optimizing infrastructure utilization in the radiation oncology department of a large university hospital and regional COVID-19 treatment center close to the first German SARS-CoV‑2 hotspot region Heinsberg in order to prevent nosocomial infections in patients and personnel during the pandemic.
Patients and methods: The study comprised year-to-date intervention analyses of in- and outpatient key procedures, machine occupancy, and no-show rates in calendar weeks 12 to 19 of 2019 and 2020 to evaluate effects of active patient flow management while monitoring nosocomial COVID-19 infections.
Results: Active patient flow management helped to maintain first-visit appointment compliance above 85.5%. A slight appointment reduction of 10.3% daily (p = 0.004) could still significantly increase downstream planning CT scheduling (p = 0.00001) and performance (p = 0.0001), resulting in an absolute 20.1% (p = 0.009) increment of CT performance while avoiding overbooking practices. Daily treatment start was significantly increased by an absolute value of 18.5% (p = 0.026). Hypofractionation and acceleration were significantly increased (p = 0.0043). Integrating strict testing guidelines, a distancing regimen for staff and patients, hygiene regulations, and precise appointment scheduling, no SARS-CoV‑2 infection in 164 tested radiation oncology service inpatients was observed.
Conclusion: In times of reduced medical infrastructure capacities and resources, controlling infrastructural time per patient as well as optimizing facility utilization and personnel workload during treatment evaluation, planning, and irradiation can help to improve appointment compliance and quality management. Avoiding recurrent and preventable exposure to healthcare infrastructure has potential health benefits and might avert cross infections during the pandemic. Active patient flow management in high-risk COVID-19 regions can help Radiation Oncologists to continue and initiate treatments safely, instead of cancelling and deferring indicated therapies.
Keywords: COVID-19, SARS-CoV-2; Disease transmission, infectious; Radiation dose hypofractionation; Radiation oncology; Stereotactic radiosurgery.
Conflict of interest statement
D. Akuamoa-Boateng, S. Wegen, J. Ferdinandus, R. Marksteder, C. Baues, and S. Marnitz declare that they have no competing interests.
Similar articles
-
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland.Strahlenther Onkol. 2020 Dec;196(12):1068-1079. doi: 10.1007/s00066-020-01681-1. Epub 2020 Sep 10. Strahlenther Onkol. 2020. PMID: 32914236 Free PMC article.
-
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.Strahlenther Onkol. 2020 Dec;196(12):1096-1102. doi: 10.1007/s00066-020-01705-w. Epub 2020 Oct 30. Strahlenther Onkol. 2020. PMID: 33125504 Free PMC article.
-
Radiotherapy in Southern Italy at the time of COVID-19: options for radiation oncology units.Int J Gynecol Cancer. 2020 Jul;30(7):917-919. doi: 10.1136/ijgc-2020-001523. Epub 2020 May 23. Int J Gynecol Cancer. 2020. PMID: 32448805
-
Facility preparedness for an obstetric unit during the Covid-19 pandemic.Natl Med J India. 2020 Nov-Dec;33(6):349-357. doi: 10.4103/0970-258X.321135. Natl Med J India. 2020. PMID: 34341213 Review.
-
Surgical activation protocol COVID-19 (SAP COVID).Cir Cir. 2021;89(1):4-11. doi: 10.24875/CIRU.20000331. Cir Cir. 2021. PMID: 33498060 Review. English.
Cited by
-
Coronavirus disease 2019 and radiation oncology-survey on the impact of the severe acute respiratory syndrome coronavirus 2 pandemic on health care professionals in radiation oncology.Strahlenther Onkol. 2022 Apr;198(4):346-353. doi: 10.1007/s00066-022-01903-8. Epub 2022 Feb 23. Strahlenther Onkol. 2022. PMID: 35195733 Free PMC article.
-
Associations between the COVID-19 Pandemic and Hospital Infrastructure Adaptation and Planning-A Scoping Review.Int J Environ Res Public Health. 2022 Jul 4;19(13):8195. doi: 10.3390/ijerph19138195. Int J Environ Res Public Health. 2022. PMID: 35805855 Free PMC article.
-
Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.Cancers (Basel). 2021 Feb 12;13(4):763. doi: 10.3390/cancers13040763. Cancers (Basel). 2021. PMID: 33673120 Free PMC article.
-
Patient flow management in biological events: a scoping review.BMC Health Serv Res. 2024 Oct 3;24(1):1177. doi: 10.1186/s12913-024-11502-1. BMC Health Serv Res. 2024. PMID: 39363291 Free PMC article.
-
Mitigating the Impact of the COVID-19 Pandemic on Adult Cancer Patients through Telehealth Adoption: A Systematic Review.Sensors (Basel). 2022 May 9;22(9):3598. doi: 10.3390/s22093598. Sensors (Basel). 2022. PMID: 35591287 Free PMC article.
References
-
- Deutsches Ärzteblatt (2020) COVID-19-Pandemie: Folgen für die onkologische kolorektale Chirurgie. https://www.aerzteblatt.de/nachrichten/112454/COVID-19-Pandemie-Folgen-f.... Accessed 31 May 2020
-
- Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17:1047–1060. doi: 10.1016/S1470-2045(16)30102-4. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous